CMA1 and pulmonary fibrosis: Because the proteolytic ability of released chymase is rapidly inactivated by antipeptidase, including endogenous protease inhibitors of serpin type,30 the impact of chymase on the degradation of apoA‐I might be more active in the loci of pulmonary fibrosis.